MPS Limited to Host Investor Call on Unbound Medicine Acquisition

MPS Limited ( (IN:MPSLTD) ) has shared an update.

MPS Limited has scheduled a conference call on 18 February 2026 to discuss its acquisition of U.S.-based Unbound Medicine Inc. The call will be led by Chairman and CEO Rahul Arora, alongside the senior management team, and will be accessible to investors via universal and toll-free dial-in numbers and an online Diamond Pass link.

The company is using the call to brief investors and stakeholders on the strategic rationale and details of the Unbound Medicine transaction, underlining the importance of the deal for its North American operations. By formally engaging the market through this dedicated event, MPS signals that the acquisition is a significant step in its growth agenda and could shape its competitive position in digital medical and professional content services.

More about MPS Limited

MPS Limited is an India-headquartered company operating in the content and publishing solutions space, serving global publishers and information providers. Through subsidiaries such as MPS North America LLC, it focuses on technology-enabled services and platforms that support digital content delivery and knowledge management for institutional and professional markets.

Average Trading Volume: 1,323

Technical Sentiment Signal: Hold

Current Market Cap: 28.15B INR

For a thorough assessment of MPSLTD stock, go to TipRanks’ Stock Analysis page.